Transaction · 0001104659-26-116965

Nelsen Robert

NELSEN ROBERT, DIR, reported a transaction classified as unknown at CITY THERAPEUTICS, INC. involving 3294900.000000 shares. Reported holdings after the transaction were 6013192.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
CTYCITY THERAPEUTICS, INC.
Trade date
Oct 19, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded3.29MPrice unknown
Holdings after6.01MIndirect · By ARCH Venture Fund XII, L.P.
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

CTY price since this filing

Daily closing prices, with the filing date and available return windows
CTY · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
unknown
Code C
Identifier
0001104659-26-116965
Common Stock
Transaction date
Oct 19, 2026
Filed Oct 19, 2026, 09:37 PM · 0d delay
Shares
3,294,900 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
6,013,192 sh
Indirect · By ARCH Venture Fund XII, L.P.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Large Holdings Increase
Filing-only score

-4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    Each share of Series Seed convertible preferred stock, Series A convertible preferred stock and Series B convertible preferred stock (collectively, the "Preferred Stock") was convertible into Common S…

  2. F2

    Shares held directly by ARCH Venture Fund XII, L.P. ("ARCH XII"). ARCH Venture Partners XII, L.P. ("AVP XII LP") is the sole general partner of ARCH XII. ARCH Venture Partners XII, LLC ("AVP XII LLC")…

  3. F3

    The shares underlying this option vest in full upon the earlier of (i) October 15, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continue…

Original filing · 0001104659-26-116965
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CTY